Literature DB >> 32611623

Quality of life, need for retreatment, and the re-equilibration phenomenon after venous sinus stenting for idiopathic intracranial hypertension.

Rebecca M Garner1, Jennifer Bernhardt Aldridge1, Stacey Q Wolfe1, Kyle M Fargen2.   

Abstract

BACKGROUND: Long term failure rates after venous sinus stenting (VSS) for idiopathic intracranial hypertension (IIH) are poorly understood.
METHODS: Retrospective analysis was performed on a prospectively-maintained single center database to identify patients with medically refractory IIH who underwent VSS. Patients with persistent or severe recurrent symptoms after VSS undergo lumbar puncture (LP), therefore LP serves as a marker for treatment failure.
RESULTS: 81 patients underwent VSS with a mean follow-up of 10 months; 44 (54.3%) patients underwent LP after VSS due to persistent or recurrent symptoms at a mean of 12 months (median 7, range 2-43). There was a mean decrease in opening pressure (OP) on LP from pre- to post-VSS of 9.1 cm H2O (median 9.5). Overall, a total of 21 (25.9%) patients underwent further surgical intervention following VSS, including five who underwent repeat VSS (6.2% of total) and 18 who underwent cerebrospinal fluid shunting (22.2% of total). There was a non-significant (p=0.18) but overall increase in quality of life scores from pre-stenting (61.2) to last follow-up (71.2), and a significant decrease in Headache Impact Test-6 (HIT-6) scores (p=0.03) with mean pre-stenting and last follow-up scores of 62.7 and 55.8, respectively.
CONCLUSIONS: VSS is an effective treatment for venous sinus stenosis in IIH; however, this study found higher rates of symptomatic recurrence and need for further surgical intervention (26%) than previously reported in the literature. Recurrence of symptoms occurred at a median of 7 months, even though OP remained lower at follow-up LP, suggestive of a re-equilibration phenomenon. © Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  intervention; intracranial pressure; stenosis

Year:  2020        PMID: 32611623     DOI: 10.1136/neurintsurg-2020-016124

Source DB:  PubMed          Journal:  J Neurointerv Surg        ISSN: 1759-8478            Impact factor:   5.836


  5 in total

Review 1.  Cerebral Venous Outflow Implications in Idiopathic Intracranial Hypertension-From Physiopathology to Treatment.

Authors:  Sorin Tuță
Journal:  Life (Basel)       Date:  2022-06-08

2.  Intra-procedural cerebral sinus thrombosis during endovascular treatment of idiopathic intracranial hypertension.

Authors:  Jorge Arturo Larco; Mehdi Abbasi; Ramanathan Kadirvel; David F Kallmes; Luis E Savastano; Waleed Brinjikji
Journal:  Neuroradiol J       Date:  2022-04-29

3.  Neuro-ophthalmological evaluation including optical coherence tomography surrounding venous sinus stenting in idiopathic intracranial hypertension with papilledema: a case series.

Authors:  Philipp Hendrix; Christopher J Whiting; Christoph J Griessenauer; Christian Bohan; Clemens M Schirmer; Oded Goren
Journal:  Neurosurg Rev       Date:  2022-01-24       Impact factor: 3.042

4.  Efficacy of dural venous sinus stenting in treating idiopathic intracranial hypertension with acute vision loss.

Authors:  Aqib H Zehri; Katriel E Lee; Jeff Kartchner; Madison Arnel; Timothy Martin; Stacey Q Wolfe; Kyle M Fargen
Journal:  Neuroradiol J       Date:  2021-07-05

5.  Intracranial Venous Hypertension and Venous Sinus Stenting in the Modern Management of Idiopathic Intracranial Hypertension.

Authors:  Robert K Townsend; Kyle M Fargen
Journal:  Life (Basel)       Date:  2021-05-31
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.